All posts by: Michael Zand

About Michael Zand

First Patient Treated In Neuralstem China Stem Cell Trial To Treat Stroke … – EIN News (press release)

First Patient Treated In Neuralstem China Stem Cell Trial To Treat Stroke …EIN News (press release)13, 2014 /PRNewswire/ — Neuralstem, Inc. (NYSE MKT: CUR) announced that the first patient was treated in the Phase I/II NSI-566 stem cell trial to treat motor deficits from ischemic stroke at BaYi Brain Hospital in Beijing, China. The patient … Continue reading

2014-01-13 NEWS

Stem Cell Research Identifies New Gene Targets in Patients With Alzheimer’s … – Science Daily (press release)

Stem Cell Research Identifies New Gene Targets in Patients With Alzheimer’s …Science Daily (press release)Jan. 9, 2014 — Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute in collaboration with scientists at the Icahn School of Medicine at Mount Sinai (ISMMS) successfully generated a stem cell model of familial Alzheimer’s disease … …read … Continue reading

2014-01-13 NEWS

Study Identifies New Stem Cell-like Population Where HIV Persists in Spite of … – Bioscience Technology

Bioscience TechnologyNow investigators from Massachusetts General Hospital (MGH) and the Ragon Institute of MGH, MIT and Harvard may have found the location where the virus hides – in a small group of recently identified T cells with stem cell-like properties. “Most human …T Memory Stem Cells Appear to Hide HIV Viral ReservoirMedscapeDiscovering where HIV persists … Continue reading

2014-01-13 NEWS

Cellular Dynamics International Inc : Nestle signs stem cell agreement with … – 4-traders (press release)

Cellular Dynamics International Inc : Nestle signs stem cell agreement with …4-traders (press release)Release date- 10012014 – The Nestle Institute of Health Sciences (NIHS) has signed a long-term agreement with a US-based developer of stem cell technologies, Cellular Dynamics International (CDI). The agreement will give the Institute access to cell … …read more   &nbs… Continue reading

2014-01-13 NEWS

BioLineRx Announces Regulatory Submission for Novel Stem Cell Mobilization … – Wall Street Journal

BioLineRx Announces Regulatory Submission for Novel Stem Cell Mobilization …Wall Street JournalSecondary objectives include assessment of the efficacy of BL-8040 in mobilizing stem cells as a stand-alone therapy, as well as monitoring the pharmacokinetic profile of the drug. This part will be performed in up to 4 cohorts, with 8 healthy … …read more   &nbs… Continue reading

2014-01-13 NEWS

BioLineRX Ltd. : BioLineRx Announces Regulatory Submission for Novel Stem … – 4-traders (press release)

BioLineRX Ltd. : BioLineRx Announces Regulatory Submission for Novel Stem …4-traders (press release)Secondary objectives include assessment of the efficacy of BL-8040 in mobilizing stem cells as a stand-alone therapy, as well as monitoring the pharmacokinetic profile of the drug. This part will be performed in up to 4 cohorts, with 8 healthy … …read more   &nbs… Continue reading

2014-01-13 NEWS